AudioScholar Psychiatry Weekly

This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning psychotropic safety and w… This week's papers: 1. Sex differences in the efficacy, acceptability, and tolerability of antipsychotics in people with acute schizophrenia: individual participant data pairwise, do… — The Lancet Psychiatry 2026 2. Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study. — PLOS Medicine 2026 3. Selective serotonin reuptake inhibitors and immune checkpoint blockade in solid tumors: A target trial emulation with pan-cancer transcriptomic analyses. — PLOS Medicine 2026 4. National Trends in Benzodiazepine Dispensing. — American Journal of Psychiatry 2026 5. Brain Stimulation Therapeutic Interventions in Neuropsychiatry: A Cambrian Explosion. — American Journal of Psychiatry 2026 6. Connectomic Determinants of Subcallosal Cingulate Deep Brain Stimulation for Depression. — American Journal of Psychiatry 2026 7. TMS-Evoked Cortical Reactivity Signatures as a Multidimensional Biomarker of Depression: A TMS-EEG Meta-Analysis from Diagnosis to Prognosis. — Biological Psychiatry 2026 8. Double-blind, randomized clinical trial targeting theta oscillations with transcranial alternating current stimulation (tACS) for cognitive control in male met… — Molecular Psychiatry 2026 9. Does high-intensity exercise combined with exposure sessions improve treatment out-comes in obsessive-compulsive disorder? A randomized controlled trial in inp… — Psychotherapy and Psychosomatics 2026 10. Change in the severity and impact of child psychiatric disorders over 3 years: an analysis of trends using the national child mental health surveys of England… — Journal of Child Psychology and Psychiatry 2026 Listen at https://audioscholar.cc/episode/yztz9swzb4

This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning prescribing safety and co… This week's papers: 1. QTc changes and early major adverse cardiovascular events associated with antidepressant treatment for major depressive disorder in adults: individual particip… — BMJ 2026 2. Comparative efficacy of antipsychotics for reducing aggression in schizophrenia: systematic review and network meta-analysis. — British Journal of Psychiatry 2026 3. Lifetime substance use disorder and suicidal behaviour: a population-based familial co-aggregation register study. — Molecular Psychiatry 2026 4. Age-Associated Cognitive Deviations in Early-Onset Psychosis Patients and Their Siblings. — American Journal of Psychiatry 2026 5. Resilience beyond diagnosis: prospective neural correlates of better-than-expected outcomes in depression. — Molecular Psychiatry 2026 6. Diagnosing autoimmune encephalitis in psychiatry: clinical recommendations and unresolved challenges from the GENERATE network. — Molecular Psychiatry 2026 7. Higher peripheral blood homocysteine levels are associated with schizophrenia: evidence from a case-control study and a meta-analysis. — Molecular Psychiatry 2026 8. In Vivo Characterization of Fatty Acid Amide Hydrolase in Posttraumatic Stress Disorder: A [11C]CURB Positron Emission Tomography Study. — Biological Psychiatry 2026 9. Neurostimulation in the treatment of psychiatric disorders: Underlying mechanisms and critical analysis of circuit-based interventions. — Molecular Psychiatry 2026 10. Irritability: what, who, how and why? — British Journal of Psychiatry 2026 Listen at https://audioscholar.cc/episode/zhchzjefnu

Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning early identification of serious mental illness, family- and child-focused interventions, and the reward circuitry that underlies depression and eating disorders,… This week's papers: 1. Psychotic and bipolar disorder diagnoses following contact with child and adolescent mental health services-a longitudinal, nationwide register study of 2 mill… — Journal of Child Psychology and Psychiatry 2026 2. Altered function of peripheral organ systems in first-episode drug naïve mental illnesses: a systematic review and meta-analysis. — Molecular Psychiatry 2026 3. Effects of an integrated parenting and mental health intervention on violence reduction and caregiver mental health among migrant and displaced families from M… — Journal of Child Psychology and Psychiatry 2026 4. Establishing a clinical cutoff score for the Family Accommodation Scale-Anxiety (FASA). — Journal of Child Psychology and Psychiatry 2026 5. Targeting the dopaminergic midbrain with precision 7-Tesla biofeedback training in depression: A proof-of-principle randomized controlled trial. — Molecular Psychiatry 2026 6. Nociceptin orphanin F/Q Pathways are dysregulated by stress and modulate reward responsiveness and motivated behavior across species. — Molecular Psychiatry 2026 7. Structural Brain Correlates of Bulimia Nervosa Diagnosis and Symptom Severity: A Coordinated ENIGMA Eating Disorders Working Group Analysis. — JAMA Psychiatry 2026 8. Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research: A Scoping Review. — JAMA Psychiatry 2026 9. The Future of Artificial Intelligence and Emerging Technologies in Mental Health: Prospects, Challenges, and a Roadmap for Personalized Treatment. — Psychotherapy and Psychosomatics 2026 10. Is cold exposure a viable lifestyle intervention for mental health? Reviewing evidence and mechanisms. — Molecular Psychiatry 2026 Listen at https://audioscholar.cc/episode/jxa84dvh6q

Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning severe mental illness treatment selection, personalised and pharmacogenomic prescribing, and the shifting landscape of child and adolescent diagnosis. Let's dive… This week's papers: 1. The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blin… — The Lancet Psychiatry 2026 2. Comparative effectiveness of mood stabiliser monotherapy versus second-generation antipsychotic monotherapy versus combination therapy for continuation and mai… — The Lancet Psychiatry 2026 3. Comparison of Long-Acting Injectable and Oral Antipsychotics in Bipolar Disorder. — American Journal of Psychiatry 2026 4. Association between CYP2D6 and CYP2C19 genotypes and venlafaxine treatment failure: a retrospective study on two cohorts from Norway and the UK. — The Lancet Psychiatry 2026 5. Improving access to antipsychotic medications for schizophrenia in Ethiopia, Nigeria, Rwanda, and South Africa: an evidence-based global consensus. — The Lancet Psychiatry 2026 6. Sex-Moderated and Sex-Specific Effects of Adverse Childhood Experiences on Neural Alcohol Cue Reactivity and Daily Craving in Individuals With Alcohol Use Diso… — American Journal of Psychiatry 2026 7. Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time. — JAMA Psychiatry 2026 8. Young minds in distress: Exploring the global rise in youth mental health diagnoses. — Molecular Psychiatry 2026 9. Annual Research Review: Sex differences in conduct disorder - revisiting existing evidence and exploring future directions. — Journal of Child Psychology and Psychiatry 2026 10. Early-childhood temperament trajectories map onto transdiagnostic psychiatric risk. — Molecular Psychiatry 2026 Listen at https://audioscholar.cc/episode/8tjb3j3pm9

Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning treatment-resistant mood disorders and neuromodulation, addiction and behavioural neuroscience, and the developmental and social determinants that shape who gets… This week's papers: 1. Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial. — JAMA Psychiatry 2026 2. Nutraceuticals and phytoceuticals for the treatment of major depressive disorder: a systematic review and network meta-analysis. — Molecular Psychiatry 2026 3. Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression. — Molecular Psychiatry 2026 4. New Horizons in the Development of Treatments for Substance Use Disorders. — American Journal of Psychiatry 2026 5. Examining the Contribution of Childhood Maltreatment to the Sex Gap in Depression: Insights from the German National Cohort (NAKO). — Psychotherapy and Psychosomatics 2026 6. Accountability in acute in-patient mental healthcare: advancing structural and cultural change. — British Journal of Psychiatry 2026 7. Menstrual Cycle Informed Psychotherapy: Preliminary findings in Women with Spider Phobia. — Psychotherapy and Psychosomatics 2026 8. Closed-loop transcranial alternating current stimulation (tACS) reduces cue reactivity and improves inhibitory control in methamphetamine use disorder with fre… — Molecular Psychiatry 2026 9. Variants of limited prosocial emotions among adolescent boys with conduct disorder. — Journal of Child Psychology and Psychiatry 2026 10. Dissecting the shared genetic architecture and biological mechanisms linking sleep traits and suicide attempts: from variants to genes. — Molecular Psychiatry 2026 Listen at https://audioscholar.cc/episode/vnh8pjhtgb